VetMotl

What VetMotl does

VetMotl, Inc. is a privately held, Maryland-incorporated medical device company that commercializes microfluidic sperm separation devices for veterinary assisted reproductive technology (ART). Founded in 2022 as a spin-off from DxNow, Inc. (alongside ZyMōt Fertility, Inc.), the company adapts a biomimetic microfluidic platform — clinically validated through more than 1.5 million human fertility cases over 10+ years — into purpose-built consumables for equine and bovine reproduction procedures including ICSI, IVF, artificial insemination, and embryo transfer.

The product portfolio comprises two SKU families (VME for equine, VMB for bovine) each offered in 850µL and 3mL input formats, plus a complimentary VetMotl Starter Kit. Devices use a membrane filter with micropores through which progressively motile sperm passively migrate into fresh media, eliminating centrifugation, special media, and reducing hands-on time to under five minutes per sample. Published evidence documents superior sperm morphology, DNA integrity, and blastocyst rates versus traditional wash, swim-up, and density-gradient methods.

VetMotl operates a direct-to-veterinarian enterprise sales motion, targeting veterinary reproduction specialists, stallion and bull stations, bovine embryo transfer businesses, and academic research institutions globally. Devices are sold in single-use sterile packs of 10 via quote-based orders managed from the Germantown, Maryland headquarters. Customers identified publicly include EquiBreed ART (New Zealand), German Standard Group (UAE), VetEmbryo (Denmark), and University of Florida researchers. The company has a 1–10 employee footprint, no disclosed institutional funding, and relies on a content-and-publication-led marketing approach supported by training videos and KOL endorsements.

Name

VetMotl

Legal name

VetMotl, Inc.

Website

https://vetmotl.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

VetMotl manufactures microfluidic sperm separation devices (VME/VMB series) for veterinary ART procedures in equine and bovine reproduction, selling directly to veterinarians, breeding stations, and embryo transfer labs worldwide.

Ownership category

akta.pro rank

Product category

Veterinary Reproductive Technology Devices

NAICS

Veterinary Services (54194)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Reproductive & Breeding Devices & Supplies (AI Equipment, Pregnancy Detection Aids) (HLAMAFAM)

akta.pro secondary industries

Embryo Transfer (ET) & IVF Services (AFAEAJAB), Artificial Insemination (AI) & Semen Services (Collection, Processing, Storage) (AFACAEAA), Reproduction, Breeding & Theriogenology (Large Animal/Equine) (HLAMABAG)

Keywords

• Veterinary medical devices
• Sperm separation devices
• Animal reproductive technology
• Microfluidic ART tools
• Equine bovine breeding

Headquarters

HQ city

Germantown

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Sperm Separation Device Sales: VetMotl generates revenue from the sale of its VME and VMB series microfluidic sperm separation devices. Devices are sold in single-use, sterile packs of 10 devices per carton. The company also sells a VetMotl Starter Kit (includes 3 devices, a Petri dish, and 9 syringes) valued at approximately $300.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

VetMotl designs, manufactures, and sells microfluidic sperm separation devices (VME and VMB series) used by veterinary reproduction professionals to prepare high-quality, high-motility sperm samples for equine and bovine assisted reproductive technology (ART) procedures, including ICSI, IVF, AI, and embryo transfer. The devices use a passive biomimetic membrane-based approach that requires no centrifugation, no special media, and under 5 minutes of hands-on time, and are sold alongside a complimentary starter kit for new customer evaluation.

Product overview

VetMotl offers a portfolio of VMB (bovine) and VME (equine) microfluidic sperm separation devices that use a biomimetic membrane-based approach to isolate high-quality, highly-motile sperm without centrifugation. The VME0850 and VMB0850 accept 850µL input with 500µL output, while the VME3000 and VMB3000 accept 3mL input with 1.0-2.5mL output depending on model. All devices operate on the same principle: semen is injected into the inlet port, passes under a membrane with micropores, and progressively motile sperm migrate through into fresh media above, separating from less motile sperm. The company also offers a complimentary starter kit (3 devices plus accessories) for evaluation purposes.

Differentiator

Problem solved

Functional benefit

Brands

• VME Series: VetMotl Multi sperm separation devices designed for equine reproduction procedures including AI, IVF, ICSI, and embryo transfers.
• VMB Series

Products and services

• VME0850 (VetMotl Multi 850µL) Sperm Separation Device

Quantifiable outcome

• In difficult mare-stallion combinations previously producing 0 embryos, VetMotl-supported protocols achieved blastocyst rates averaging 26.5% (range 16.7-50%) per injected oocyte
• +5 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• ZyMōt Fertility, Inc.coreTechnology or IntegrationVetMotl Sperm Separation Devices are derived from the core technology inherent in ZyMōt® Sperm Separation Devices, developed by Utkan Demirci's research group and commercialized by ZyMōt Fertility. ZyMōt devices have been used in over 1,000 human fertility clinics worldwide for over 10 years in 1.5 million+ clinical cases. VetMotl was formed as a spin-off from DxNow, Inc. (alongside ZyMōt Fertility) to commercialize the technology specifically for veterinary applications.
• DxNow, Inc.coreTechnology or IntegrationDxNow, Inc. was the parent company from which both ZyMōt Fertility, Inc. and VetMotl, Inc. were formed. William T. Sharp was co-founder, Chairman and CEO of DxNow, which spun out the ZyMōt and VetMotl businesses. DxNow developed microfluidic cell sorting technologies including those used in IVF applications.

Scale indicators2 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Select Sires: Large U.S. cooperative providing bovine AI, semen processing, and reproductive services. Comparable as a downstream consumer of advanced bovine reproductive technologies and a potential channel partner.
• IMV Technologies: International leader in animal reproduction biotechnology, offering AI, embryo transfer, and cryopreservation products across multiple species. Comparable broad incumbent serving overlapping veterinary reproduction customers.
• ABS Global: Major bovine genetics and reproduction company providing AI services, sexed and conventional semen, and embryo transfer programs worldwide. Comparable as a large-scale bovine reproduction service and technology provider.
• Hamilton Thorne: Publicly traded provider of precision instruments, consumables, and software for animal reproduction and ART (equine and bovine), including laser systems for ICSI. Comparable as an established veterinary ART device supplier targeting similar end customers.
• DxNow: Parent company from which VetMotl was spun out. DxNow developed the foundational microfluidic cell-sorting IP used in both ZyMōt and VetMotl products and remains an enabling technology stakeholder for the platform.
• Inguran / Sexing Technologies: Dominant provider of sexed semen technology for bovine AI globally. Comparable as a large-scale bovine reproduction technology business that touches VetMotl's downstream workflow and customer base.
• Minitube: Global supplier of reproductive technologies for livestock and companion animals, including semen extenders, AI equipment, embryo transfer devices, and ART consumables. Comparable broad incumbent in the same veterinary reproduction supply chain.

Regional players

• Trans Ova Genetics: Leading U.S. provider of bovine embryo transfer and IVF services with a strong commercial ETB network. Comparable as a large-scale downstream consumer of bovine sperm preparation technology in North America.
• Alta Genetics: Global bovine genetics and reproduction services company offering AI programs, reproductive consulting, and dairy/beef genetic solutions. Comparable downstream channel for advanced bovine reproduction technology.

Direct peers

• ZyMōt Fertility: Sister company spun out of DxNow using the same core microfluidic sperm separation technology. ZyMōt commercializes the human fertility version of the device across 1,000+ clinics globally and represents the most direct technology peer to VetMotl.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/vetmotl-inc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VetMotl